Archives of Facial Plastic Surgery, 7(1), 27-31
J3490 is the unclassified drug code, used only when no specific J-code exists for the drug administered
Pre-clinical reports describe increased follicle size, prolonged anagen phase, and improved scalp vascularization in animal studies and ex-vivo follicle cultures [8]
Standard treatments like semaglutide and tirzepatide deliver substantial clinical outcomes for the majority of patients
More importantly, the nanoscale dimension and high surface-area-to-volume ratio of these carriers facilitate enhanced intestinal uptake via multiple mechanisms, and in some cases, may even enable partial circumvention of hepatic first-pass metabolism (18, 19)
When used properly as a diluent, it is generally considered well tolerated